Growth in America
Revenue grew especially in America despite exchange rate effects.
“Adjusted for the impact of exchange rate changes, revenue grew by 40.2 percent in America and 33.0 percent in APAC. Growth of 11.7 percent in Northern Europe was due to an Energy & Cleantech customer,” commented CEO Christophe Sut.
According to Sut, Ebita growth was supported by increased volumes and the company’s efficiency measures.
Scanfil divides its customers into three groups: Industrial, Energy & Cleantech (energy, circular economy, and electrification), and Medtech & Life Science (medical technology).
Of these, Energy & Cleantech and Medtech & Life Science grew.
In Energy & Cleantech, revenue grew by 26.1 percent, which, according to Sut, was due to strongly progressing customer project wins.
“We remain very confident about the long-term development of this customer group. New customer projects were won during the quarter totaling 18.4 million euros.”
Medtech’s growth was 16 percent.
“We signed an agreement with a significant customer, which supports the long-term development of Medtech & Life Science,” Sut commented.
“New customer projects were won during the quarter totaling 15.3 million euros.”
The revenue of the Industrial customer group decreased by 2.3 percent compared to the previous year’s reference period. According to Sut, volumes are expected to stabilize in the future.